You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 8, August 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lupus Erythematosus and Miller-Fisher Syndrome

Roland Bingisser, MD; Rudolf Speich, MD; Adriano Fontana, MD; Jürg Gmür, MD; Barbara Vogel, MD; Theodor Landis, MD

Arch Neurol. 1994;51(8):828-830.


Abstract

Objective
To compare the clinical course of an unusual case of Miller-Fisher syndrome in systemic lupus erythematosus with therapeutic interventions, in particular with plasma exchanges.

Design
The clinical state and laboratory and electrophysiologic parameters were controlled for over a year and related to therapeutic attempts with immunoglobulins, steroids, and plasma exchanges.

Setting
Medical intensive care unit of a university hospital.

Patient
A 17-year-old black female student with known systemic lupus erythematosus who developed ataxia, areflexia, and ophthalmoplegia (Miller-Fisher syndrome) and later became tetraplegic and required full mechanical ventilatory support.

Results
High-dose immunoglobulin treatment combined with corticosteroid pulse therapy was not beneficial. However, plasma exchange (performed five times over a period of 4 months) was followed by a striking clinical improvement within hours after each plasma exchange.

Conclusions
Plasma exchange appears to remove a yet unknown agent producing a distal motor nerve conduction block and is efficacious in severe neuropathy associated with Miller-Fisher syndrome in lupus erythematosus.



Author Affiliations

From the Departments of Internal Medicine (Drs Bingisser, Speich, Fontana, and Gmür) and Neurology (Drs Vogel and Landis), University Hospital, Zürich, Switzerland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular manifestations of systemic lupus erythematosus
Sivaraj et al.
Rheumatology (Oxford) 2007;46:1757-1762.
ABSTRACT | FULL TEXT  

Ocular manifestations of systemic lupus erythematosus: a clinical review
Peponis et al.
Lupus 2006;15:3-12.
ABSTRACT  

A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response
Levy et al.
Lupus 1999;8:705-712.
ABSTRACT  

Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin
Sherer et al.
Lupus 1999;8:324-327.
ABSTRACT  

Eye Movement Abnormalities in Systemic Lupus Erythematosus
Keane
Arch Neurol 1995;52:1145-1149.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.